Efficacy of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight, eating behavior, and glycemic control, in Japanese obese type 2 diabetes

Efficacy of liraglutide, a glucagon-like peptide-1 (GLP-1) analogue, on body weight, eating behavior, and glycemic control, in Japanese obese type 2 diabetes

<p>Abstract</p> <p>Background</p> <p>We recently reported that short-term treatment with liraglutide (20.0 ± 6.4 days) reduced body weight and improved some scales of eating behavior in Japanese type 2 diabetes inpatients. However, it remained uncertain whether such lir...

Full description

Bibliographic Details
Main Authors: Fujishima Yuya, Maeda Norikazu, Inoue Kana, Kashine Susumu, Nishizawa Hitoshi, Hirata Ayumu, Kozawa Junji, Yasuda Tetsuyuki, Okita Kohei, Imagawa Akihisa, Funahashi Tohru, Shimomura Iichiro
Format: Article
Language:English
Published: BMC 2012-09-01
Series:Cardiovascular Diabetology
Subjects:
Liraglutide
Glucagon-like peptide-1 (GLP-1)
Obesity
Eating behavior
Diabetes
Incretin
Online Access:http://www.cardiab.com/content/11/1/107

Internet

http://www.cardiab.com/content/11/1/107

Similar Items